---
annotation-target: blood.2022017616.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-15T02:17:19.691Z","updated":"2022-09-15T02:17:19.691Z","document":{"title":"blood.2022017616.pdf","link":[{"href":"urn:x-pdf:94502fdaac0e3aea61ca5016b35ad659"},{"href":"vault:/hematology-theroy/papers/covid19withblood/blood.2022017616.pdf"}],"documentFingerprint":"94502fdaac0e3aea61ca5016b35ad659"},"uri":"vault:/hematology-theroy/papers/covid19withblood/blood.2022017616.pdf","target":[{"source":"vault:/hematology-theroy/papers/covid19withblood/blood.2022017616.pdf","selector":[{"type":"TextPositionSelector","start":5500,"end":5554},{"type":"TextQuoteSelector","exact":"monoclonal  gammopathy  of  undetermined  significance","prefix":"37 therapies5.  Patients  with  ","suffix":" 38 (MGUS)  are  at  increased  "}]}]}
>```
>%%
>*%%PREFIX%%37 therapies5.  Patients  with%%HIGHLIGHT%% ==monoclonal  gammopathy  of  undetermined  significance== %%POSTFIX%%38 (MGUS)  are  at  increased*
>%%LINK%%[[#^ktpsme1qesm|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^ktpsme1qesm


>%%
>```annotation-json
>{"created":"2022-09-15T02:20:44.940Z","updated":"2022-09-15T02:20:44.940Z","document":{"title":"blood.2022017616.pdf","link":[{"href":"urn:x-pdf:94502fdaac0e3aea61ca5016b35ad659"},{"href":"vault:/hematology-theroy/papers/covid19withblood/blood.2022017616.pdf"}],"documentFingerprint":"94502fdaac0e3aea61ca5016b35ad659"},"uri":"vault:/hematology-theroy/papers/covid19withblood/blood.2022017616.pdf","target":[{"source":"vault:/hematology-theroy/papers/covid19withblood/blood.2022017616.pdf","selector":[{"type":"TextPositionSelector","start":6181,"end":6470},{"type":"TextQuoteSelector","exact":"Severe COVID-19 infection was defined using the original study definition 46 adopted for the mRNA vaccine study [presence of respiratory failure, evidence of shock, 47 significant  acute  renal,  hepatic,  or  neurologic  dysfunction,  admission  to  an  intensive 48 care unit, or death]1","prefix":"n (Supplementary 45 Figure  1). ","suffix":". During the timeframe of study,"}]}]}
>```
>%%
>*%%PREFIX%%n (Supplementary 45 Figure  1).%%HIGHLIGHT%% ==Severe COVID-19 infection was defined using the original study definition 46 adopted for the mRNA vaccine study [presence of respiratory failure, evidence of shock, 47 significant  acute  renal,  hepatic,  or  neurologic  dysfunction,  admission  to  an  intensive 48 care unit, or death]1== %%POSTFIX%%. During the timeframe of study,*
>%%LINK%%[[#^10nvl8v4eey|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^10nvl8v4eey


>%%
>```annotation-json
>{"created":"2022-09-15T02:25:32.902Z","updated":"2022-09-15T02:25:32.902Z","document":{"title":"blood.2022017616.pdf","link":[{"href":"urn:x-pdf:94502fdaac0e3aea61ca5016b35ad659"},{"href":"vault:/hematology-theroy/papers/covid19withblood/blood.2022017616.pdf"}],"documentFingerprint":"94502fdaac0e3aea61ca5016b35ad659"},"uri":"vault:/hematology-theroy/papers/covid19withblood/blood.2022017616.pdf","target":[{"source":"vault:/hematology-theroy/papers/covid19withblood/blood.2022017616.pdf","selector":[{"type":"TextPositionSelector","start":14032,"end":14465},{"type":"TextQuoteSelector","exact":"The  lack  of  correlative  neutralizing  antibody  data  after 126 vaccination  is  a  limitation  in  assessing  vaccine  efficacy  in  patients  with  MGUS.  In 127 conclusion, one-fourths of the patient population with MGUS and a COVID-19 infection 128 had a severe infection with immunoparesis being an independent predictor of severe 129 infection. Advanced age was the only independent risk factor for higher risk of mortality","prefix":" 125 patients  with  MGUS  16.  ","suffix":".     130  131 Authorship: M.H, "}]}]}
>```
>%%
>*%%PREFIX%%125 patients  with  MGUS  16.%%HIGHLIGHT%% ==The  lack  of  correlative  neutralizing  antibody  data  after 126 vaccination  is  a  limitation  in  assessing  vaccine  efficacy  in  patients  with  MGUS.  In 127 conclusion, one-fourths of the patient population with MGUS and a COVID-19 infection 128 had a severe infection with immunoparesis being an independent predictor of severe 129 infection. Advanced age was the only independent risk factor for higher risk of mortality== %%POSTFIX%%.     130  131 Authorship: M.H,*
>%%LINK%%[[#^l7h9lrdyq8|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^l7h9lrdyq8
